Journal ArticleOPEN ACCESS

Post-COVID-19 co-morbidity of emerged Lophomonas infection and invasive pulmonary aspergillosis: First case report

Clinical Case Reports (2021) 9(9)
DOI: 10.1002/ccr3.4822
10Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Due to long corticosteroid therapy in patients with COVID-19, in case of cough, dyspnea, and weight loss, emerging pulmonary aspergillosis and lophomoniasis should be ruled out.

Author supplied keywords

Cite

CITATION STYLE

APA

Sharifpour, A., Zakariaei, Z., Fakhar, M., Banimostafavi, E. S., Nakhaei, M., & Soleymani, M. (2021). Post-COVID-19 co-morbidity of emerged Lophomonas infection and invasive pulmonary aspergillosis: First case report. Clinical Case Reports, 9(9). https://doi.org/10.1002/ccr3.4822

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free